EXENS — Exosens SAS Cashflow Statement
0.000.00%
Last trade - 00:00- €2.25bn
- €2.43bn
- €394.08m
- 74
- 10
- 70
- 49
Annual cashflow statement for Exosens SAS, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -15.8 | -149 | 11.2 | 18.4 | 30.7 |
| Depreciation | |||||
| Non-Cash Items | 48.2 | 182 | 17.2 | 29.7 | 44.9 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 3.71 | -2.18 | -1.51 | -28.5 | -16.2 |
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 44.1 | 42.7 | 47.5 | 50.5 | 96.3 |
| Capital Expenditures | -13.8 | -19.6 | -21.8 | -30.9 | -41.3 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | -1.67 | -33.7 | -68.7 | -31.5 |
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -13.8 | -21.3 | -55.5 | -99.6 | -72.7 |
| Financing Cash Flow Items | -9.33 | -13.4 | -13.8 | -20.3 | -31.4 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -5.01 | -36.8 | 20.3 | 35.5 | 76.3 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 25.1 | -15.2 | 12.4 | -13.5 | 100 |